OpenVSafe by OpenVAERS
Search V-safe

YUK-22276-65305

5 vaccinations 5 coded responses 20 check-ins 4 free-text entries 2 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
110 / NY
Registered
2021-03-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-03
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-18
    Registered in v-safe
  3. 2021-03-18
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-03-24
    Dose 2 — Pfizer-BioNTech
  5. 2021-03-24
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-03-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  7. 2021-03-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Constipation — Feeling: Good
    Free text: Constipation Thursday and Friday following Wednesdays immunization
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-03-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-04-02
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-04-07
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-14
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-04-22
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-04-28
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-05
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-06-23
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-09-22
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-10-09
    Dose 3 — Pfizer-BioNTech
  19. 2022-03-26
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2022-05-04
    Dose 4 — Pfizer-BioNTech
  21. 2022-09-14
    Dose 5 — Pfizer-BioNTech
  22. 2022-10-14
    Survey response — day 28, dose 5
    MedDRA: Chemotherapy, Pancreatic carcinoma, Pre-existing disease — Feeling: Good
    Free text: Receiving Chemo therapy for pancreas cancer recently discovered on my liver. I had previously undergone distal pancreas surgery in November 2020.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-10-19
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  24. 2022-10-26
    Survey response — day 42, dose 5
    MedDRA: Dysphagia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: I had some trouble swallowing for a few days after my last chemo treatment. This may have been caused by the chemo.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-10-26
    Report sent to call center — day 42, dose 5
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  26. 2022-10-28
  27. 2022-12-14
    Survey response — 3 months, dose 5
    MedDRA: Chemotherapy, Condition aggravated, Metastases to liver, Pancreatic carcinoma metastatic, Pre-existing disease — Feeling: Good
    Free text: Undergoing chemo for relapse of pancreatic cancer. November 2020 surgery cured the cancer, but pancreas cancer landed on my liver in summer of 2022. This led to chemo scheduled for September through February. Excellent prognosis for healthy future.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2023-03-15
    Survey response — 6 months, dose 5
    MedDRA: Adverse drug reaction, Chemotherapy, Office visit, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  29. 2023-03-15
    Report sent to call center — 6 months, dose 5
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  30. 2023-03-16
  31. 2023-03-16

Vaccinations

DoseDateManufacturerCo-administered
12021-03-03Pfizer-BioNTech
22021-03-24Pfizer-BioNTech
32021-10-09Pfizer-BioNTech No
42022-05-04Pfizer-BioNTech No
52022-09-14Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-10-26 Unsuccessful
2023-03-15 Unsuccessful

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-27

Systemic reaction (other): Constipation Thursday and Friday following Wednesdays immunization

Release 12 — day 28, dose 5

2022-10-14

Symptoms: Receiving Chemo therapy for pancreas cancer recently discovered on my liver. I had previously undergone distal pancreas surgery in November 2020.

Release 12 — day 42, dose 5

2022-10-26

Symptoms: I had some trouble swallowing for a few days after my last chemo treatment. This may have been caused by the chemo.

Release 12 — 3 months, dose 5

2022-12-14

Symptoms: Undergoing chemo for relapse of pancreatic cancer. November 2020 surgery cured the cancer, but pancreas cancer landed on my liver in summer of 2022. This led to chemo scheduled for September through February. Excellent prognosis for healthy future. cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAdverse drug reaction · · ✓
SDChemotherapy · · ✓
SDCondition aggravated · · ✓
SDDysphagia · · ✓
SDMetastases to liver · · ✓
SDOffice visit · · ✓
SDPancreatic carcinoma · · ✓
SDPancreatic carcinoma metastatic · · ✓
SDPre-existing disease · · ✓
SDUnevaluable event · · ✓
SROConstipation ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release